In January and May this year we had noted that a company called Churchill Pharmaceuticals has been developing a different formulation of ultramicron-sized, oral abiraterone acetate (to be called Yonsa™). … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: abiraterone, Churchill, formulation, submicron, Yonsa | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 